Interim Drug-Resistant Tuberculosis Guidelines

Interim Drug-Resistant Tuberculosis (TB) Guidelines provide temporary recommendations for diagnosing and treating TB that does not respond to standard medicines. These guidelines help healthcare providers quickly identify resistant cases, especially when complete testing results aren’t available yet. They outline effective treatment regimens to combat resistant strains and prevent further spread, ensuring patients receive appropriate care promptly. While these are provisional, they are based on the best available evidence and will be updated as more information becomes accessible, aiming to improve outcomes for individuals and public health overall.